Advertisement

Journal of Community Health

, Volume 42, Issue 6, pp 1127–1132 | Cite as

Factors Associated with HPV Vaccination in Young Males

  • Kelli M. Fuller
  • Leslie Hinyard
Original Paper

Abstract

Human papilloma virus (HPV) affects both men and women; however, recommendations for HPV vaccination among men were not issued in the United States until 2011. The purpose of this study was to describe and compare characteristics of men who did and did not report receiving at least one dose of the HPV vaccine. Data from the ten states that completed the HPV vaccination module in the 2013 Behavioral Risk Factor Surveillance System (BRFSS) were included in the study. Young men ages 18–26 were included (N = 1624). Categorical variables were compared between those who did and did not receive the HPV vaccine using Chi square. Logistic regression was used to examine the odds of HPV vaccination by the above factors. Only 16.5% of men reported at least one dose of HPV vaccine. Having health insurance, having a primary doctor, and receiving an HIV test were predictive of HPV vaccination. Men in Texas were more likely to report HPV vaccination than all other states. Overall, HPV vaccination is low in men. Targeted interventions for improving HPV vaccination rates in men are warranted, especially for those without health insurance or a routine source of care.

Keywords

HPV vaccines Males BRFSS 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest to report.

References

  1. 1.
    Anderson, M., Dobkin, C., & Gross, T. (2012). The effect of health insurance coverage on the use of medical services. American Economic Journal: Economic Policy, 4(1), 1–27.Google Scholar
  2. 2.
    American Cancer Society. (2016). HPV vaccines: What is HPV? Retrieved from http://www.cancer.org/cancer/cancercauses/othercarcinogens/infectiousagents/hpv/hpv-faq.
  3. 3.
    Canepa, P., Orsi, M., Martini, M., & Icardi, G. (2013). HPV related diseases in males: A heavy vaccine-preventable burden. Journal of Preventative Medicine and Hygiene, 54(2), 61–70.Google Scholar
  4. 4.
    Centers for Disease Control and Prevention. (2016). Behavioral risk factor surveillance system. Retrieved January 4, 2017 from http://www.cdc.gov/brfss/.
  5. 5.
    Centers for Disease Control and Prevention. (2016). Genital HPV infection-fact sheet. Retrieved January 4, 2017 from http://www.cdc.gov/std/hpv/stdfact-hpv.htm.
  6. 6.
    Centers for Disease Control and Prevention. (2016). How many cancers are linked with HPV each year? Retrieved January 17, 2017 from http://www.cdc.gov/cancer/hpv/statistics/cases.htm.
  7. 7.
    Centers for Disease Control and Prevention. (2016). HPV and men-fact sheet. Retrieved January 18, 2017 from http://www.cdc.gov/std/hpv/stdfact-hpv-and-men.htm.
  8. 8.
    Centers for Disease Control and Prevention. (2016). Vaccines for children program. Retrieved February 1, 2017 from http://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/.
  9. 9.
    Centers for Disease Control. (2016). Vaccines for children program. Retrieved February 2, 2017 from https://www.cdc.gov/vaccines/programs/vfc/about/index.html.
  10. 10.
    Centers for Disease Control and Prevention. (2015). Human papilloma virus: questions and answers. Retrieved February 7, 2017. http://www.cdc.gov/hpv/parents/questions-answers.html.
  11. 11.
    Cifu, A. S., & Davis, A. M. (2014). Use of HPV vaccine in males and females. JAMA, Clinical Guidelines Synopsis, 312(18), 1920–1921.Google Scholar
  12. 12.
    Donahue, K. L., Stupiansky, N. W., Alexander, A. B., & Zimet, G. D. (2014). Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons. Vaccine, 32(31), 3883–3885. doi: 10.1016/j.vaccine.2014.05.035.CrossRefPubMedGoogle Scholar
  13. 13.
    Gerend, M. A., Shepherd, M. A., Lustria, M. L., & Shepherd, J. E. (2016). Predictors of provider recommendation for HPV vaccine among young adult men and women: Findings from a cross sectional survey, Sexually Transmitted Infections, 92, 104–107. doi: 10.1136/sextrans-2015-052088.CrossRefPubMedGoogle Scholar
  14. 14.
    Khan, L. (2017). Human papilloma virus and the HPV vaccine: Where are we today? Pediatric Annals, 46(1), e2–e5. doi: 10.3928/19382359-20161216-01.CrossRefPubMedGoogle Scholar
  15. 15.
    Katz, M. L., Krieger, J. L., & Roberto, A. (2011). HPV: College male’s knowledge, perceived risk, sources of information vaccine barriers and communication. Journal of Men’s Health, 8(3), 175–184. doi: 10.1016/j.jomh.2011.04.002.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Kornfeld, J., Byrne, M. M., Vanderpool, R., Shin, S., & Kobetz, E. (2013). HPV knowledge and vaccine acceptability among Hispanic fathers. Journal of Primary Prevention, 34(1–2), 59–69.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Liddon, N., Hood, J., Wynn, B. A., & Markowitz, L. E. (2010). Acceptability of human papillomavirus vaccine for males: A review of the literature. Journal of Adolescent Health, 46, 113–123. doi: 10.1016/j.jadohealth.2009.11.199.CrossRefPubMedGoogle Scholar
  18. 18.
    Lu, P., Yankey, D., Jeyarajah, J., O’Halloran, A., Elam-Evans, L. D., Smith, P. J., Stokley, S., Singleton, J. A., & Dunne, E. F. (2015). HPV vaccination coverage of male adolescents in the United States. Pediatrics, 136(5), 839–849. doi: 10.1542/peds.2015-1631.CrossRefPubMedGoogle Scholar
  19. 19.
    Markowitz, L. E., Dunne, E. F., Saraiya, M., Chesson, H. W., Curtis, C. R., Gee, J., Bocchini, J. A., Unger, E. R. (2014). Human papillomavirus vaccination: Recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report, 63(RRO5), 1–30. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6305a1.htm.
  20. 20.
    Petrosky, E., Bocchini, J. J., Hariri, S., Chesson, H., Curtis, C. R., Saraiya, M., et al. (2015). Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report, 64(11), 300–304.PubMedGoogle Scholar
  21. 21.
    Ratanasiripong, N. T. (2015). Factors related to human papilloma virus (HPV) vaccination in college men. Public Health Nursing, 3(6), 645–653. doi: 10.1111/phn.12198.CrossRefGoogle Scholar
  22. 22.
    Reiter, P. L., McRee, A. L., Kadis, J. A., & Brewer, N. T. (2011). HPV vaccine and adolescent males. Vaccine, 29(34), 5595–5602. doi: 10.1016/j.vaccine.2011.06.020.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Stanley, M. (2016). Preventing cervical cancer and genital warts-How much protection is enough for HPV vaccines? Journal of Infection. doi: 10.1016/j.jinf.2016.04.018.PubMedGoogle Scholar
  24. 24.
    Stanley, M. (2014). HPV vaccination in boys and men. Human Vaccines and Immunotherapeutics, 10(7), 2106–2108. doi: 10.4161/hv.29137.CrossRefPubMedCentralGoogle Scholar
  25. 25.
    Stokley, S., Jeyarajah, J., Yankey, D., Cano, M., Gee, J., Roark, J., Curtis, R., & Markowirz, L. (2014). HPV vaccination coverage among adolescents, 2007–2013, and post-licensure vaccine safety monitoring, 2006–2014. Morbidity and Mortality Weekly Report, 63(29), 620–624.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Saint Louis University School of NursingSt. LouisUSA
  2. 2.Saint Louis University Center for Health Outcomes ResearchSt. LouisUSA

Personalised recommendations